Live Breaking News & Updates on Managing Director Dr Krishna

Stay updated with breaking news from Managing director dr krishna. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Bharat Biotech To Supply 3.5 Crore Covaxin Doses In September And 5 Crore In October; 10 Crore Monthly Supply Likely Only In 2022

Bharat Biotech To Supply 3.5 Crore Covaxin Doses In September And 5 Crore In October; 10 Crore Monthly Supply Likely Only In 2022
swarajyamag.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from swarajyamag.com Daily Mail and Mail on Sunday newspapers.

Andhra Pradesh , Krishna Ella , Covaxin To Centre , Bharat Biotech , Managing Director Dr Krishna , Human Resource , Drugs Controller General ,

Maharashtra scouts for 12 cr vax for 18-45 age group


Maharashtra scouts for 12 cr vax for 18-45 age group
​ By
IANS
|
​ 7 Views
Maharashtra scouts for 12 cr vax for 18-45 age group. Image Source: IANS News
Mumbai, April 27 : Barely 72 hours before the ambitious phase of vaccination for 18-45 age groups begins from May 1, the Maharashtra government has started scouting around for getting sufficient quantities of the Covid-19 jabs, officials said here on Tuesday.
Health Department Principal Secretary Dr Pradeep Vyas has sent separate letters to Serum Institute of India CEO Adar Poonawala and Bharat Biotech International Ltd Chairman and Managing Director Dr Krishna M. Ella to the effect.
He said that if the Maharashtra government decides to vaccinate its 18-45 age group population, estimated at around 5-crore, then it would require some 12-crore vaccine doses. ....

United States , Krishnam Ella , Adar Poonawala , Health Department Principal , Serum Institute Of India , Bharat Biotech International Ltd , Department Principal Secretary Dr Pradeep Vyas , Serum Institute , Bharat Biotech International Ltd Chairman , Managing Director Dr Krishna , ஒன்றுபட்டது மாநிலங்களில் , கிருஷ்ணம் எல்லா , அடார் பூனாவள , ஆரோக்கியம் துறை ப்ரிந்ஸிபல் , சீரம் நிறுவனம் ஆஃப் இந்தியா , பாரத் பயோடெக் சர்வதேச லிமிடெட் , சீரம் நிறுவனம் , நிர்வகித்தல் இயக்குனர் டாக்டர் கிருஷ்ணா ,

Maharashtra scouts for 12 crore Covid vaccines for 18-45 age group


 0
Barely 72 hours before the ambitious phase of vaccination for 18-45 age groups begins from May 1, the Maharashtra government has started scouting around for getting sufficient quantities of the Covid-19 jabs, officials said here on Tuesday.
 
Health Department Principal Secretary Dr Pradeep Vyas has sent separate letters to Serum Institute of India CEO Adar Poonawala and Bharat Biotech International Ltd Chairman and Managing Director Dr Krishna M. Ella to the effect.
 
He said that if the Maharashtra government decides to vaccinate its 18-45 age group population, estimated at around 5-crore, then it would require some 12-crore vaccine doses.
 
Vyas asked the two how many doses of Covishield (SII) and Covaxin (BBIL) vaccines the two companies could supply to the state government, per month over the next six months from May 2021 onwards. ....

United States , Krishnam Ella , Adar Poonawala , Health Department Principal , Serum Institute Of India , Bharat Biotech International Ltd , Department Principal Secretary Dr Pradeep Vyas , Serum Institute , Bharat Biotech International Ltd Chairman , Managing Director Dr Krishna , Mutual Fund Returns , Ank Fixed Deposits , Nvestor Returns , Ortfolio Allocation , ஒன்றுபட்டது மாநிலங்களில் , கிருஷ்ணம் எல்லா , அடார் பூனாவள , ஆரோக்கியம் துறை ப்ரிந்ஸிபல் , சீரம் நிறுவனம் ஆஃப் இந்தியா , பாரத் பயோடெக் சர்வதேச லிமிடெட் , சீரம் நிறுவனம் , நிர்வகித்தல் இயக்குனர் டாக்டர் கிருஷ்ணா , பரஸ்பர நிதி வருமானம் ,

Brazil's Covaxin order still active, says Bharat Biotech after regulator denies certification


Brazil s Covaxin order still active, says Bharat Biotech after regulator denies certification
​ By
IANS
|
​ 4 Views
 
Bharat Biotech recruits 13,000 volunteers for Phase III trials of Covaxin. Image Source: IANS News
Hyderabad, April 1 : Bharat Biotech has said that Brazil government s order of 20 million doses of Covid-19 Covaxin is still active and that it will fulfil certain requirements pointed out during the inspection by Brazilian health regulator Anvisa.
The Hyderabad-based vaccine maker s clarification came after reports that Anvisa denied permission to import Bharat Biotech s Covaxin into the country
The health regulator refused to grant a certification of Good Manufacturing Practices (GMP) to Covaxin, citing non-compliance with necessary standards. It suspended the request of Brazil s health ministry to import the vaccine. ....

Andhra Pradesh , Emanuela Medrades , Andre Aranha Correa , Krishna Ella , Precisa Medicamentos , National Institute Of Virology , Indian Council Of Medical Research , Bharat Biotech , Good Manufacturing Practices , Genome Valley , Bharat Biotech Chairman , Managing Director Dr Krishna , Indian Council , Medical Research , Biosafety Level , ஆந்திரா பிரதேஷ் , ஆண்ட்ரே அரன்ஹா கொரியா , கிருஷ்ணா எல்லா , தேசிய நிறுவனம் ஆஃப் வைராலஜி , இந்தியன் சபை ஆஃப் மருத்துவ ஆராய்ச்சி , பாரத் பயோடெக் , நல்ல உற்பத்தி ப்ர்யாக்டிஸஸ் , மரபணு பள்ளத்தாக்கு , பாரத் பயோடெக் தலைவர் , நிர்வகித்தல் இயக்குனர் டாக்டர் கிருஷ்ணா , இந்தியன் சபை ,